Allegheny Singer Rsrch Inst — research payments reported

By program year

6 rows

Year	Kind	Amount	Payments
2024	Research	$7,350	6
2023	Research	$53,925	15
2022	Research	$2,100	2
2021	Research	$4,500	6
2020	Research	$7,646	7
2019	Research	$11,172	14

Breakdown

Who paid Research payments · program years 2019–2024

Janssen Research & Development, LLC $55,732 31 payments
SI-BONE, Inc. $24,515 15 payments
Actelion Pharmaceuticals, Ltd $6,446 4 payments

Studies the money was for Research payments · program years 2019–2024

54767414Amy2009 $27,000 5 payments
Saffron $17,875 9 payments
Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia A Multi Center Randomized Double blind Placebo controlled Study $12,000 4 payments
A Phase 3 study comparing daratumumab . Lenalidomide and dexamethasone DRd versus lenalidomide and Dexamethasone Rd in patients with newly diagnosed multiple myeloma who are not eligible for high dose chemotherapy and autologous stem cell transplant $11,000 11 payments
Lois $6,640 6 payments
A Phase 3 study comparing daratumumab . Lenalidomide and dexamethasone (DRd) versus lenalidomide and Dexamethasone (Rd) in patients with newly diagnosed multiple myeloma who are not eligible for high dose chemotherapy and autologous stem cell transplant $5,732 11 payments
The Efficacy and Safety of Initial Triple Versus Initial Dual Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial Hypertension $5,196 3 payments
Clinical Study to Assess the Efficacy and Safety of Macitentan in Patients With Pulmonary Hypertension After Left Ventricular Assist Device Implantation $1,250 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.